In Brief
This article was originally published in The Tan Sheet
Executive Summary
Sunset Natural Products falls on labeling, GMPs; FDA raps Coral Rock Man for new drugs; Hillestad GMP response puzzles FDA; Natural Medicine products cross the line; ensure quality of botanical ingredients, AHPA’s Dentali says; Emerson distributes Heel homeopathics; Jakobsen takes reins at Mead Johnson.
You may also be interested in...
In Brief
Perrigo divests personal hygiene assets; P&G sues whitening strip private labeler; Purimune contamination prompts Baby Move recall; FDA sounds alarm on Oto-Ease recall; more news In Brief.
People In Brief
Jakobsen next in line as Mead Johnson CEO; Blake takes over Bayer U.S. from Babe; Himmel ends brief tenure as ChromaDex CEO; Capitol Hill veteran O’Donnell joins NACDS; Merz makes Hartman derma VP; USANA strengthens scientist roster; more People In Brief.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.